• 22005 Citations
  • 71 h-Index
1984 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 29 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Pancreaticoduodenectomy Medicine & Life Sciences
Neoadjuvant Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2019

1 Citations

Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer

Bernard, V., Kim, D. U., San Lucas, F. A., Castillo Arias, J. A., Allenson, K., Mulu, F. C., Stephens, B. M., Huang, J., Semaan, A., Guerrero, P. A., Kamyabi, N., Zhao, J., Hurd, M. W., Koay, E. J., Taniguchi, C., Herman, J. M., Javle, M., Wolff, R. A., Katz, M. H., Varadhachary, G. R. & 2 othersMaitra, A. & Alvarez, H. A., Jan 1 2019, In : Gastroenterology. 156, 1, p. 108-118.e4

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Nucleic Acids
Exosomes
Circulating Neoplastic Cells
DNA
2 Citations

Adjuvant or Neoadjuvant Therapy in the Treatment in Pancreatic Malignancies: Where Are We?

Wolff, R. A., Feb 1 2018, In : Surgical Clinics of North America. 98, 1, p. 95-111 17 p.

Research output: Contribution to journalReview article

Neoadjuvant Therapy
Neoplasms
Therapeutics
Survival
Pancreatic Neoplasms

Clinical decision-making in pancreaticcancer

Wolff, R. A., Apr 11 2018, Pancreatic Cancer. Springer New York, p. 601-632 32 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pancreatic Neoplasms
Patient Care Planning
Neoadjuvant Therapy
Caregivers
Therapeutics
1 Citations

Dynamic changes during the treatment of pancreatic cancer

Wolff, R. A., Wang-Gillam, A., Alvarez, H. A., Tiriac, H., Engle, D., Hou, S., Groff, A. F., Lucas, A. S., Bernard, V., Allenson, K., Castillo Arias, J. A., Kim, D., Mulu, F., Huang, J., Stephens, B., Wistuba, I. I., Katz, M. H., Varadhachary, G. R., Park, Y. K., Hicks, J. & 10 othersChinnaiyan, A., Scampavia, L., Spicer, T., Gerhardinger, C., Maitra, A., Tuveson, D., Rinn, J., Lizee, G. A., Yee, C. & Levine, A. J., Jan 1 2018, In : Oncotarget. 9, 19, p. 14764-14790 27 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Organoids
Therapeutics
Immunotherapy
Neoplasms
gemcitabine
Adenocarcinoma
Drug Therapy
130-nm albumin-bound paclitaxel
Confidence Intervals